The Scottsdale Interventional Forum 2020 (SIF 2020) has been designed to meet the ever-increasing needs of cardiovascular specialists to diagnose and manage the most complex cardiovascular disease states. This comprehensive, state of the art four-day symposium provides an in-depth review of the most relevant advances in the treatment of heart and vascular disease. The organizing committee for SIF 2020 is committed to creating a thorough, all-encompassing scientific curriculum to meet the needs of cardiovascular specialists attending this nationally recognized educational event.
Now in its 16th year, SIF 2020 will again utilize a talented, world class faculty to provide an in-depth understanding of pathophysiologic disease mechanisms, advanced diagnostic imaging, a Heart Team approach to problem solving as well as an update of the most innovative therapeutic options for complex disease management. This course will include a series of high-level didactic lectures, case presentations from world experts and live case transmissions from leading centers throughout the country. This synthesis of a concentrated educational experience and expert commentary from a distinguished faculty provides a superb learning environment for physicians, nurses and allied health professionals.
As in past, SIF 2020 will include a variety of hands-on workshops and specialty symposia. Given the rapid evolution in diagnostic and therapeutic strategies for treating coronary artery disease patients, the SIF Faculty will review the most pertinent diagnostic studies and management issues pertaining to complex coronary intervention. With evolutions in antiplatelet duration and antithrombotic therapies, an update on state-of-the-art pharmacologic management of coronary disease patients will be highlighted. The treatment of unprotected left main disease, chronic total occlusions (CTO’s), and an expert panel review of novel DES platforms will be featured in both the didactic and live case sessions. Amongst those sessions highlighted at this year’s Forum will be the use of Impella and other advanced methodologies for circulatory support; the nation’s experts in mechanical circulatory support will provide a day-long session in complex percutaneous coronary intervention. Attendees will have an “up-close-and-personal” access to these experts during the four-day meeting.
Emphasis on plaque modification technologies including high speed rotational atherectomy, intravascular lithotripsy, orbital atherectomy and scoring / cutting balloon applications will also take center stage during the complex coronary interventions sessions.
There is a growing need for the interventional cardiologist to understand the pharmacologic and catheter-based management options for atrial fibrillation, traditionally the domain of rhythm management specialists. With growing interest in mechanical left atrial appendage therapies, SIF will feature live cases and a lecture series on left atrial appendage closure. Watchman and other mechanical left atrial appendage devices currently in development will be discussed in didactic
lectures and live case presentations. As renal denervation has evolved into a more realistic and viable therapeutic option for hypertension patients, we will examine the ongoing interest in this technology.
There may be no field of research and innovation more exciting for cardiovascular specialists and more relevant to an aging US demographic than the diagnosis and management of patients with valvular heart disease. Understanding newer modalities and technological breakthroughs in catheter-based therapy of valvular heart disease will be emphasized in multiple sessions. The transcatheter aortic valve replacement (TAVR) symposium will highlight best practices for patients with severe aortic stenosis, valve replacement for low risk patients, treatment options for patients with aortic insufficiency and a review of new TAVR devices in development. The economics of TAVR and other structural therapies will also be covered.
There has been a tremendous interest in the treatment of those stricken with mitral and tricuspid valvular heart disease. Developing an expert consensus on the best management of those with degenerative mitral valve disease is essential. Practitioners are challenged by the decision as to which mechanical therapy for functional mitral regurgitation might provide the most durable results for patients. These topics will receive in depth analysis by our panel of world experts. Finally, the emerging transcatheter therapies for a burgeoning population with tricuspid and pulmonic valvular disease will be comprehensively reviewed.
In summary, SIF 2020 is intended to provide physicians, nurses, and allied health attendees the most comprehensive, state-of-the-art review of diagnostic imaging and management strategies for the treatment of those afflicted with advanced cardiovascular disorders. The goal of this four-day CME Symposium is simple: Provide the requisite skills to advance bedside patient management, apply innovative therapies in the most practical manner and quantifiably improve the outcomes of our patients suffering from cardiovascular disease.
• Live satellite broadcasts from the top US centers covering complex coronary and structural intervention
• Comprehensive didactic lectures from the world’s leading experts in cardiovascular disease management
• Up-close and personal interaction with leading cardiovascular specialists
• Stimulating taped case presentations covering the most complex interventional complications
• Extensive review of mechanical circulatory support and percutaneous intervention
• A robust review of the latest advances in the therapy of valvular and structural heart disease
• Comprehensive, hands-on mini symposia, fellows course and dedicated nursing symposium
• Advanced imaging symposia
The 2020 Scottsdale Interventional Forum has been designed to meet the educational needs of interventional and general cardiologists, cardiology fellows, cardiovascular surgeons and vascular specialists, interventional radiologists, cath lab nurses and technicians as well as other medical professionals who have an interest in heart and vascular medicine.
7500 E. Doubletree Ranch Road Scottsdale, Arizona 85258